202288-08-2

Upstream product

• 90-05-1 2-methoxy-phenol 
• 3473-63-0 formamidine acetic acid 
• 150726-89-9 (2-methoxyphenoxy)-malonic acid dimethyl ester 

Downstream Products

• 150727-23-4 4,6-dichloro-5-(o-methoxyphenoxy)-pyrimidine 
• 202288-09-3 4-tert-butyl-N-[6-(4-hydroxy-butoxy)-5-(2-methoxy-phenoxy)-pyrimidin-4-yl]-benzenesulfonamide 
• 150727-24-5 4-tert-butyl-N-[6-chloro-5-(o-methoxyphenoxy)-4-pyrimidinyl]-benzene sulfonamide 

Relevant academic research and scientific papers

Synthesis and structure-activity relationships of potent and orally active sulfonamide ETB selective antagonists

The synthesis and structure-activity relationships of a series of N-pyrimidinyl benzenesulfonamides as ETB selective antagonists are described. N-Isoxazolyl benzenesulfonamide 1a, previously reported, was selected as a lead compound, and isosteric replacement of the isoxazole ring of 1a with a pyrimidine ring led to the discovery of the highly potent ETB selective antagonist 6e with oral bioavailability. Modification of the terminal aldehyde group at the 6-position of the pyrimidine ring was investigated, and malonate 15b and acylhydrazone 16f were found to be equipped to aldehyde 6e. Compound 6e showed ETB antagonistic activity on in vivo evaluation. Copyright